Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxyverine bromide aerosol in COPD (phase 2)
CTR20132673Phase 2Completed
- Sponsor
- Chengdu List Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxyverine bromide in chronic obstructive pulmonary disease (COPD), sponsored by Chengdu List Pharmaceutical. Started May 2014; status: completed.
02
Drugs
pentoxyverine bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20132673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132673.